Crossmark

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

Crossref DOI link: https://doi.org/10.1186/s12967-016-1005-7

Published Online: 2016-09-02

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Medrano, Luz M.

Rallón, Norma

Berenguer, Juan

Jiménez-Sousa, María A.

Soriano, Vicente

Aldámiz-Echevarria, Teresa

Fernández-Rodríguez, Amanda

García, Marcial

Tejerina, Francisco

Martínez, Isidoro

Benito, José M.

Resino, Salvador https://orcid.org/0000-0001-8783-0450
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (CD14/00002)

Instituto de Salud Carlos III (CD13/00013)

Instituto de Salud Carlos III (CP14/0010)

Instituto de Salud Carlos III (CP14/00198)

Instituto de Salud Carlos III (RD12/0017/0024)

Instituto de Salud Carlos III (RD12/0017/0031)

Instituto de Salud Carlos III (MPY 1404/15)

Instituto de Salud Carlos III (PI14CIII/00011)